News

Wegovy News Pushes Novo Nordisk Stock Higher

Novo Nordisk’s wildly popular GLP-1 drug Wegovy has been approved for use against a serious form of liver disease.

Ozempic sales surge as priced-out Mounjaro patients seek cheaper alternative

Ozempic sales have risen five-fold after a 126 per cent rise in the price of the Mounjaro drug due to pressure from US ...
BioPharma Dive5h

Novo’s Wegovy becomes first GLP-1 drug approved for MASH

The FDA clearance sets Novo’s medicine up a market battle with Madrigal Pharmaceuticals’ fast-selling Rezdiffra.
GlobalData on MSN7h

Wegovy becomes first GLP-1RA to gain FDA MASH approval

The drug received accelerated approval for use in patients with metabolic dysfunction-associated steatohepatitis (MASH).

Mounjaro rivals Wegovy and Retatrutide explained as price hiked for millions of users

Many Mounjaro users are looking into alternative medications following news of a 170 percent price increase in the UK ...
GCN1hOpinion

Lilly to raise UK Mounjaro price 170%

Lilly to raise UK Mounjaro price 170% from £122 to £330 monthly amid White House push for European drug price increases to ...

Weight-loss drug Wegovy launches in South Africa

The launch marked Danish drugmaker Novo Nordisk's debut on the continent, ramping up competition with rival Eli Lilly.

Novo Nordisk debuts Wegovy in South Africa as weight-loss drugs race gathers pace

Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...

Rival fat jab WON’T increase in price, makers pledge – as Mounjaro set to double in costs

MAKERS of the fat jab Wegovy say they will not increase the price of the drug when the cost of rival Mounjaro doubles next ...